Synthesis of carbohydrate mimics: α-1-C-substituted-deoxymannojirimycins

Tetrahedron Letters

Volumn 38, Issue 46, 1997, Pages 7977-7980

  Johnson, Carl R ^a   Johns, Brian A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; 1 DEOXYMANNONOJIRIMYCIN DERIVATIVE; GLYCOSIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0030727057     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)10144-7     Document Type: Article

References (26)

1. (a) Rademacher, T.W.; Parekh, R.B.; Dwek, R.A. Ann. Rev. Biochem. 1988, 57, 785.
2. (b) Varki, A. Glycobiology 1993, 3, 97.
3. (c) Dwek, R.A. Chem. Rev. 1996, 96, 683.
4. For viral disorders: (a) Sunkara, P.S.; Bowlin, T.L.; Liu, P.S.; Sjoerdsma, A. Biochem. Biophys. Res. Commun. 1987, 148, 206.
5. (b) Gruters, R.A.; Neefjes, J.J.; Tersmette, M.; de Goede, R.E.Y.; Tulp, A.; Huisman, H.G.; Miedema, F.; Ploegh, H.L. Nature, 1987, 330, 74.
6. (c) Walker, B.D.; Kowalski, M.; Goh, W.C.; Kozarsky, K.; Krieger, M.; Rosen, C.; Rohrschneider, L.; Haseltine, W.A.; Sodroski, J. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 8120.
7. (d) Karpas, A.; Fleet, G.W.J.; Dwek, R. A.; Petersson, S.; Namgoong, S.K.; Ramsden, N.G.; Jacob, G.S.; Rademacher, T.W. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9229.
8. For cancer: (a) Humphries, M.J.; Matsumoto, K.; White, S.L.; Olden, K. Cancer Res. 1986, 46, 5215.
9. (b) Spearman, M.A.; Jamieson, J.C.; Wright, J.A. Exp. Cell Res. 1987, 168, 116.
10. For diabetes and other metabolic disorders (a) Truscheit, E.; Frommer, W.; Junge, B.; Müller, L.; Schmidt, D.D.; Wingender, W. Angew. Chem. Int. Ed. Engl. 1981, 20, 744.
11. (b) Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. J. Med. Chem. 1986, 29, 1038.
12. (c) Anzeveno, P.B.; Creemer, L.J.; Daniel, J.K.; King, C-H. R.; Liu, P.S. J. Org. Chem. 1989, 54, 2539.
13. (a) Johnson, C.R.; Miller, M.W.; Golebiowski, A.; Sundram, H.; Ksebati, M.B. Tetrahedron Lett. 1994, 35, 8991.
14. (b) Johns, B.A.; Pan, Y.T.; Elbein, A.D.; Johnson, C.R. J. Am. Chem. Soc. 1997, 119, 4856.
15. (c) Johnson, C.R.; Johns, B.A. J. Org. Chem. 1997, 62, (in press).
16. For a recent report of a C-glycoside with the α-manno configuration used as a M. tuberculosis inhibitor see Jarreton, O.; Skrydstrup, T.; Beau, J.-M. J. Chem. Soc. Chem. Commun. 1996, 1661. For α-manno mimics of Sialyl Lewis X see Marron, T.G.; Woltering, T.J.; Weitz-Schmidt, G.; Wong, C.-H. Tetrahedron Lett. 1996, 37, 9037.
17. For a recent report of a C-glycoside with the α-manno configuration used as a M. tuberculosis inhibitor see Jarreton, O.; Skrydstrup, T.; Beau, J.-M. J. Chem. Soc. Chem. Commun. 1996, 1661. For α-manno mimics of Sialyl Lewis X see Marron, T.G.; Woltering, T.J.; Weitz-Schmidt, G.; Wong, C.-H. Tetrahedron Lett. 1996, 37, 9037.
18. The diol derived from bromobenzene is now prepared in crystalline form on a multikilogram scale by Genecor International, Inc., Rochester, NY. For a nice overview of applications of such cis-cyclohexadienediols see Hudlickly, T.; Thorpe, A.J. J. Chem. Soc. Chem. Commun. 1996, 1993.
19. (a) Miyaura, N.; Yanagi, T.; Susuki, A. Synth. Commun. 1981, 11, 513.
20. (b) Miyaura, N.; Ishiyama, T.; Sasaki, H.; Ishikawa, M.; Satoh, M.; Suzuki, A. J. Am. Chem. Soc. 1989, 111, 314.
21. (c) Suzuki, A. Pure Appl. Chem. 1991, 63, 419.
22. (d) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
23. All compounds reported above have been fully characterized. For data see Johns, B.A. Ph.D. Dissertation, Wayne State University, 1997.
24. Ring closure during mesylation has been reported for similar cases see Bonnaud, B.; Bigg, D.C.H. J. Heterocyclic Chem. 1993, 30, 505.
25. Mereyala, H.B.; Gaddam, B.R. J. Chem. Soc. Perkin Trans. 1 1994, 2187.
26. Abdel-Magid A.F., Maryanoff C.A., Carson K.G. Tetrahedron Lett. 31:1990;5595.